First, the phase 3 trial of Moderna’s norovirus vaccine had to endure a clinical hold. Now, the study has to head back for a second season in the Northern Hemisphere after failing to find enough cases down south.
<a href="https://www.fiercebiotech.com/biotech/modernas-norovirus-phase-3-study-heads-north-again-after-struggling-find-cases" hreflang="en">Moderna's phase 3 norovirus study heads north again after struggling to find cases down south</a>
FierceBiotech | | James Waldron
Topics: cervical-cancer, clinical-trials, research